A Phase 2, Randomized, Double Blind, Placebo Controlled Study of AMG 386 in Combination With FOLFIRI in Subjects With Previously Treated Metastatic Colorectal Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Metastases
Related studies linked through entity extraction aliases.
Alpharadin™ (Radium-223 Chloride) Safety and Dosimetry With HRPC That Has Metastasized to the Skeleton
- Status
- COMPLETED
- Phase
- PHASE1
Multiple Dose Study In Cancer Patients: Safety and Tolerability of BMS-754807 in Advanced or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Pre- and Post-operative FOLFOX Based Therapy for Patients With Colorectal Cancer With Liver Involvement
- Status
- TERMINATED
- Phase
- PHASE2
PRISM (Panitumumab Regimen In Second-line Monotherapy of Head and Neck Cancer)
- Status
- COMPLETED
- Phase
- PHASE2
Irinotecan Discontinuation and Reintroduction for Advanced Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Phase III Trial of DP Followed by FOLFIRI or the Reverse Sequence in Unresectable Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Evaluation of the Efficacy of Xaliproden (SR57746A) in Preventing the Neurotoxicity of Oxaliplatin / 5FU/LV Chemotherapy.
- Status
- COMPLETED
- Phase
- PHASE3
XENOX - Evaluation of the Efficacy of Xaliproden in Reducing the Neurotoxicity of the Oxaliplatin + 5-FU/LV Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE3
Using TRAP to Evaluate the Effect of Zometa on Bone Metastasis Due to Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Evaluating Panitumumab (ABX-EGF) Plus Best Supportive Care Versus Best Supportive Care in Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Interferon-Beta Gene Transfer (Ad.hIFN-β) as Treatment for Refractory Colorectal Carcinoma With Liver Metastases
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Research Study for Patients With Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Activity of 90Y-Labeled IDEC-159 in Subjects With Metastatic Colorectal Adenocarcinoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study of M200 (Volociximab) in Patients With Metastatic Renal Cell Carcinoma (RCC)
- Status
- TERMINATED
- Phase
- PHASE2
Volociximab in Combination With DTIC in Patients With Metastatic Melanoma Not Previously Treated With Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
DPPE in Combination With Epirubicin and Cyclophosphamide in the Treatment of Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE3
A Study of Patients With HER2 Gene Amplified Metastatic Breast Cancer Treated With First Line Herceptin and a Taxane
- Status
- COMPLETED
- Phase
- N/A
A Study to Evaluate Avastin in Patients Treated in a Previous Genentech-Sponsored Cancer Study
- Status
- COMPLETED
- Phase
- PHASE3
BMS-599626 in Patients With Advanced Solid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1